Literature DB >> 10791989

Immunomodulation of cancer: potential use of selectively replicating agents.

S Agha-Mohammadi1, M T Lotze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10791989      PMCID： PMC315454          DOI： 10.1172/JCI10026

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

1.  Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability.

Authors:  F Belli; F Arienti; J Sulé-Suso; C Clemente; L Mascheroni; A Cattelan; C Santantonio; G F Gallino; C Melani; S Rao; M P Colombo; M Maio; N Cascinelli; G Parmiani; C Sanatonio
Journal:  Cancer Immunol Immunother       Date:  1997-06       Impact factor: 6.968

Review 2.  Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes.

Authors:  P Leroy; P Slos; H Homann; P Erbs; Y Poitevin; E Regulier; F Q Colonna; P Devauchelle; C Roth; A Pavirani; M Mehtali
Journal:  Res Immunol       Date:  1998 Sep-Oct

3.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

Authors:  S Worgall; G Wolff; E Falck-Pedersen; R G Crystal
Journal:  Hum Gene Ther       Date:  1997-01-01       Impact factor: 5.695

Review 4.  Tumor immunotherapy by vaccination with cytokine gene transfected cells.

Authors:  C Viret; A Lindemann
Journal:  Int Rev Immunol       Date:  1997       Impact factor: 5.311

5.  Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.

Authors:  V Juillard; P Villefroy; D Godfrin; A Pavirani; A Venet; J G Guillet
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

6.  Tumour therapy in mice using adenovirus vectors expressing human TNFa.

Authors:  R A Marr; M Hitt; W J Muller; J Gauldie; F L Graham
Journal:  Int J Oncol       Date:  1998-03       Impact factor: 5.650

7.  A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response.

Authors:  Z Abdel-Wahab; C Weltz; D Hester; N Pickett; C Vervaert; J R Barber; D Jolly; H F Seigler
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

Review 8.  Gene therapy for cancer: what have we done and where are we going?

Authors:  J A Roth; R J Cristiano
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

9.  Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

Authors:  H Wakimoto; J Abe; R Tsunoda; M Aoyagi; K Hirakawa; H Hamada
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

10.  A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy.

Authors:  S O Freytag; K R Rogulski; D L Paielli; J D Gilbert; J H Kim
Journal:  Hum Gene Ther       Date:  1998-06-10       Impact factor: 5.695
View more
  8 in total

Review 1.  Prodrug-activating systems in suicide gene therapy.

Authors:  C J Springer; I Niculescu-Duvaz
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Regulatable systems: applications in gene therapy and replicating viruses.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 3.  Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.

Authors:  T Hermiston
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 4.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

5.  A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma.

Authors:  Fred T Valentine; Frederick M Golomb; Matthew Harris; Daniel F Roses
Journal:  Oncoimmunology       Date:  2017-10-30       Impact factor: 8.110

6.  Antitumor immunity induced by irradiated tumor cells producing macrophage colony-stimulating factor.

Authors:  S Suzu; F Kimura; M Tanaka-Douzono; M Yamada; Y Nakamura; N Wakimoto; K Sato; T Morita; K Ikeda; K Motoyoshi
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

Review 7.  Clinical translation of immunomodulatory therapeutics.

Authors:  Amanda Nash; Samira Aghlara-Fotovat; Andrea Hernandez; Christopher Scull; Omid Veiseh
Journal:  Adv Drug Deliv Rev       Date:  2021-07-27       Impact factor: 17.873

Review 8.  Targeted nonviral gene therapy in prostate cancer.

Authors:  Najla Altwaijry; Sukrut Somani; Christine Dufès
Journal:  Int J Nanomedicine       Date:  2018-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.